|
1
|
Jiangsu New Medical College. Dictionary
Traditional Drugs. Shanghai Scientific and Technical Publishers;
Shanghai: pp. 411993
|
|
2
|
Whelan LC and Ryan MF: Ethanolic extracts
of Euphorbia and other ethnobotanical species as inhibitors
of human tumour cell growth. Phytomedicine. 10:53–58. 2003.
|
|
3
|
Bruni R, Muzzoli M, Ballero M, Loi MC,
Fantin G, Poli F and Sacchetti G: Tocopherols, fatty acids and
sterols in seeds of four Sardinian wild Euphorbia species.
Fitoterapia. 75:50–61. 2004. View Article : Google Scholar
|
|
4
|
Hore SK, Ahuja V, Mehta G, Kumar P, Pandey
SK and Ahmad AH: Effect of aqueous Euphorbia hirta leaf
extract on gastrointestinal motility. Fitoterapia. 77:35–38.
2006.
|
|
5
|
Shi HM, Williams ID, Sung HH, Zhu HX, Ip
NY and Min ZD: Cytotoxic diterpenoids from the roots of
Euphorbia ebracteolata. Planta Med. 71:349–354. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ruan HL, Zhang Y and Zhang YH: Studies on
constituents from roots of Euphorbia hylonoma. Zhongguo
Zhong Yao Za Zhi. 31:742–744. 2006.(In Chinese).
|
|
7
|
Cao D, SU YL and Yang JS: Triterpene
constituents from Euphorbia nemtocypha Hand-Mazz. Yao Xue
Xue Bao. 27:445–451. 1996.(In Chinese).
|
|
8
|
Chaabi M, Michel VF, Frossard N,
Randriantsoac A, Andriantsitohainad R and Lobstein A:
Anti-proliferative effect of Euphorbia stenoclada in human
airway smooth muscle cells in culture. J Ethnopharmacol.
109:134–139. 2007.
|
|
9
|
Valente C, Pedro M, Duarte A, Nascimento
MS, Abreu PM and Ferreira MJ: Bioactive diterpenoids, a new
jatrophane and two ent-Abietanes, and other constituents from
Euphorbia pubescens. J Nat Prod. 67:902–904. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang WF, Cui Z and Zhu Q: Cytotoxicity
and antiviral activity of the compounds from Euphorbia
kansui. Planta Med. 64:754–756. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yasukawa K, Akihisa T, Yoshida ZY and
Takido M: Inhibitory effect of euphol, a triterpene alcohol from
the roots of Euphorbia kansui, on tumor promotion by
12-O-Tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in
mouse skin. J Pharm Pharmacol. 52:119–124. 2000.PubMed/NCBI
|
|
12
|
Guo ZJ, Zhu R, Lu JX and Li YL: Chemical
constituents of Euphorbia hylonoma Hand. -Mazz. Zhongguo
Zhongyao Zazhi. 20:744–745. 1995.(In Chinese).
|
|
13
|
Ruan HL, Zhou XF, Zhang YH, Pi HF, Wu JZ
and Sun HD: Ferulic acid esters from Euphorbia hylonoma.
Fitoterapia. 78:72–73. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo ZJ, Lu Juxian, Li YL, et al: Studies
on pharmacognosy of Euphorbia hylonoma Hand-Nazz. J Xi’an
Med Univ. 3:313–315. 3181996.(In Chinese).
|
|
15
|
Guo ZJ, Lu X, Li YL and Zhu R: The studies
on resource of Euphorbia genus in Shaanxi province.
Northwest Pharm J. 11(Suppl 1): 6–7. 1996.
|
|
16
|
Liu RH, Chen LL and Kong LY: Ellagic Acid
Derivatives from the Stem Bark of Sapius sebiferum. Zhong
Guo Yao Ke Da Xue Xue Bao Bian Ji Bu. 5:370–373. 2002.(In
Chinese).
|
|
17
|
Hong YX and Wei GY: Studies on the
chemical constituents from leaves of Diplopanax stachyathus.
Zhong Cao Yao Bian Ji Bu. 2:125–127. 2004.(In chinese).
|
|
18
|
Duffy MJ, McGowan PM and Gallagher WM:
Cancer invasion and metastasis: changing views. J Pathol.
214:283–293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maas JL and Galletta GJ: Ellagic acid, an
anticarcinogen in fruits, especially in strawberries: a review.
Hortscience. 26:10–14. 1991.
|
|
20
|
Thresiamma KC, George J and Kuttan R:
Protective effect of curcumin, ellagic acid and bixin on radiation
induced genotoxicity. J Exp Clin Cancer Res. 17:431–434.
1998.PubMed/NCBI
|
|
21
|
Mandal S and Stoner GD: Inhibition of
N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats
by ellagic acid. Carcinogenesis. 11:55–61. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sohn EH, Koo HJ, Hang DT, et al:
Protective effects of ellagic acid on ethanol-induced toxicity in
hepatic HepG2 cells. Mol Cell Toxicol. 9:249–256. 2013. View Article : Google Scholar
|
|
23
|
Lu HF, Tsou MF, Lin JG, Ho CC, Liu JY,
Chuang JY and Chung JG: Ellagic acid inhibits growth and arylamine
N-acetyltransferase activity and gene expression in
Staphylococcus aureus. In Vivo. 19:195–199. 2005.PubMed/NCBI
|
|
24
|
Sayer JM, Yaji H, Wood AW, et al:
Extremely facile reaction between the ultimate carcinogen
benzo[a]pyrene-7,8-diol 9,10-epoxide and ellagic acid. J Am Chem
Soc. 104:5562–5564. 1982.
|
|
25
|
Take Y, Imouye Y, Nakamura S, et al:
Comparative studies of the inhibitory properties of antibiotics on
human immunodeficiency virus and avian myeloblastosis virus reverse
transcriptases and cellular DNA polymerases. J Antibiot (Tokyo).
42:107–115. 1989. View Article : Google Scholar
|
|
26
|
Stoner GD and Morse MA: Isothiocyanates
and plant polyphenols as inhibitors of lung and esophageal cancer.
Cancer Lett. 114:113–119. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Narayanan BA, Geoffroy O, Willingham MC,
Re GG and Nixon DW: P53/p21 (WAF1/CIP1) expression and its possible
role in G1 arrest and apoptosis in ellagic acid treated cancer
cells. Cancer Lett. 136:215–221. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ahn D, Putt D, Kresty L, Stoner GD, Fromm
D and Hollenberg PF: The effects of dietary ellagic acid on rat
hepatic and esophageal mucosal cytochromes P450 and phase II
enzymes. Carcinogenesis. 17:821–828. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Falsaperla M, Morgia G, Tartarone A,
Ardito R and Romano G: Support ellagic acid therapy in patients
with hormone refractory prostate cancer (HRPC) on standard
chemotherapy using vinorelbine and estramustine phosphate. Eur
Urol. 47:449–454. 2005. View Article : Google Scholar
|
|
30
|
Labrecque L, Lamy S, Chapus A, et al:
Combined inhibition of PDGF and VEGF receptors by ellagic acid, a
dietary-derived phenolic compound. Carcinogenesis. 26:821–826.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arulmozhi V, Pandian K and Mirunalini S:
Ellagic acid encapsulated chitosan nanoparticles for drug delivery
system in human oral cancer cell line (KB). Colloids Surf B
Biointerfaces. 110:313–320. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rommel A and Wrolstad RE: Ellagic acid
content of red rasp2 berry juice as influenced by cultivar,
processing, and environ2 mental factors. J Agric Food Chem.
41:1951–1960. 1993. View Article : Google Scholar
|
|
33
|
Rafter JJ: Scientific basis of biomarkers
and benefits of functional foods for reduction of disease risk:
cancer. Br J Nutr. 88(Suppl 2): S219–S224. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Potter JD: Cancer prevention: epidemiology
and experiment. Cancer Lett. 114:7–9. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roy M, Chakrabarty S, Sinha D,
Bhattacharya RK and Siddiqi M: Anticlastogenic, antigenotoxic and
apoptotic activity of epigallocatechin gallate: a green tea
polyphenol. Mutat Res. 523–524:33–41. 2003.PubMed/NCBI
|
|
36
|
Kong AN, Owuor E, Yu R, Hebbar V, Chen C,
Hu R and Mandlekar S: Induction of xenobiotic enzymes by the MAP
kinase pathway and the antioxidant or electrophile response element
(ARE/EpRE). Drug Metab Rev. 33:255–271. 2001. View Article : Google Scholar
|
|
37
|
Park AM and Dong Z: Signal transduction
pathways: targets for green and black tea polyphenols. J Biochem
Mol Biol. 36:66–77. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Loo G: Redox-sensitive mechanisms of
phytochemical mediated inhibition of cancer cell proliferation. J
Nutr Biochem. 14:64–73. 2003.PubMed/NCBI
|
|
39
|
Heber D and Lu QY: Overview of mechanisms
of action of lycopene. Exp Biol Med (Maywood). 227:920–923.
2002.PubMed/NCBI
|
|
40
|
O’Neill JW and Hockenbery DM:
Bcl-2-related proteins as drug targets. Current Med Chem.
10:1553–1562. 2003.
|
|
41
|
Cory S and Adams JM: Killing cancer cells
by flipping the Bcl-2/Bax switch. Cancer Cell. 8:5–6. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fathi NA, Hussein MR, Hassan HI, Mosad E,
Galal H and Afifi NA: Glomerular expression and elevated serum
Bcl-2 and Fas proteins in lupus nephritis: preliminary findings.
Clin Exp Immunol. 146:339–343. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang R, Xue YY, Lu SD, Wang Y, Zhang LM,
Huang YL, Signore AP, Chen J and Sun FY: Bcl-2 enhances
neurogenesis and inhibits apoptosis of newborn neurons in adult rat
brain following a transient middle cerebral artery occlusion.
Neurobiol Dis. 24:345–356. 2006. View Article : Google Scholar
|
|
44
|
Karlnoski R, Wilcock D, Dickey C, Ronan V,
Gordon MN, Zhang W, Morgan D and Taglialatela G: Up-regulation of
Bcl-2 in APP transgenic mice is associated with neuroprotection.
Neurobiol Dis. 25:179–188. 2007. View Article : Google Scholar
|
|
45
|
Bernas T, Asem EK, Robinson JP, Cook PR
and Dobrucki JW: Confocal fluorescence imaging of photosensitized
DNA denaturation in cell nuclei. Photochem Photobiol. 81:960–969.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yoshida A, Takemura H, Inoue H, Miyashita
T and Ueda T: Inhibition of glutathione synthesis overcomes
Bcl-2-mediated topoisomerase inhibitor resistance and induces
nonapoptotic cell death via mitochondrial-independent pathway.
Cancer Res. 66:5772–5780. 2006. View Article : Google Scholar
|
|
47
|
Degli EM: Mitochondria in apoptosis: past,
present and future. Biochem Soc Trans. 32:493–495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dias N and Bailly C: Drugs targeting
mitochondrial functions to control tumor cell growth. Biochem
Pharmacol. 70:1–12. 2005.PubMed/NCBI
|
|
49
|
Sedlak TW, Oltvai ZN, Yang E, Wang K,
Boise LH, Thompson CB and Korsmeyer SJ: Multiple Bcl-2 family
members demonstrate selective dimerizations with Bax. Proc Natl
Acad Sci USA. 92:3834–3838. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Riedl SJ and Shi Y: Molecular mechanisms
of caspase regulation during apoptosis. Nat Rev Mol Cell Biol.
5:897–907. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
51
|
Nunẽza G, Benedict MA, Hu Y and Inohara
N: Caspases: the proteases of the apoptotic pathway. Oncogene.
17:3237–3245. 1998.
|
|
52
|
Fan TJ, Han LH, Cong RS and Liang J:
Caspase family proteases and apoptosis. Acta Biochim Biophys Sin
(Shanghai). 37:719–727. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dassé E, Bridoux L, Baranek T, Lambert E,
Salesse S, Sowa ML, Martiny L, Trentesaux C and Petitfrère E:
Tissue inhibitor of metalloproteinase-1 promotes hematopoietic
differentiation via caspase-3 upstream the MEKK1/MEK6/p38alpha
pathway. Leukemia. 21:595–603. 2007.PubMed/NCBI
|
|
54
|
Lanvin O, Gouilleux F, Mullié C, Mazière
C, Fuentes V, Bissac E, Dantin F, Mazière JC, Régnier A, Lassoued K
and Gouilleux-Gruart V: Interleukin-7 induces apoptosis of 697
pre-B cells expressing dominant-negative forms of STAT5: evidence
for caspase-dependent and -independent mechanisms. Oncogene.
23:3040–3047. 2004. View Article : Google Scholar
|
